Rare Leukemic Phase of Follicular Lymphoma With a High-Risk Follicular Lymphoma International Prognostic Index (FLIPI) Score Treated With Bendamustine-Rituximab
Cureus · 30.05.2026
DOI: 10.7759/cureus.109914 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 30.05.2026. Verfasst von Niyati Bansal und 2 weiteren Autor:innen. Beteiligte Einrichtung: General Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
- Hematology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
- Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Zitieren
APA
Bansal, N., Thomas, S., & Shanmugam, S. G. (2026). Rare Leukemic Phase of Follicular Lymphoma With a High-Risk Follicular Lymphoma International Prognostic Index (FLIPI) Score Treated With Bendamustine-Rituximab. Cureus. https://doi.org/10.7759/cureus.109914
Vancouver
Bansal N, Thomas S, Shanmugam SG. Rare Leukemic Phase of Follicular Lymphoma With a High-Risk Follicular Lymphoma International Prognostic Index (FLIPI) Score Treated With Bendamustine-Rituximab. Cureus. 2026. doi:10.7759/cureus.109914
BibTeX
@article{Bansal2026,
author = {Bansal, Niyati and Thomas, Steve and Shanmugam, Sri Gayathri},
title = {Rare Leukemic Phase of Follicular Lymphoma With a High-Risk Follicular Lymphoma International Prognostic Index (FLIPI) Score Treated With Bendamustine-Rituximab},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.109914}
}
EUVIMED